These data were presented today during a late-breaking session at the American Heart Association (AHA) Scientific Sessions and published simultaneously in The New England Journal of Medicine (NEJM) in ...
The data presented by Judo Bio at ASN showed preclinical translation of megalin-STRIKERs from rodents to non-human primates, and from target gene silencing to functional pharmacodynamic effect. Key ...
Trial results consistent with prospective design of these antibodies to have distinct profiles – one to provide stronger anticoagulation and the other to have a lower risk of bleeding – potentially ...
This study is a multicenter, randomized, double-blind, placebo-controlled clinical trial in China that enrolled 318 adult patients with IgAN at high risk of progression who had received stable ...
Jade Biosciences Presents New Data Demonstrating a Favorable Preclinical Safety Profile of JADE101 and a Translational Analysis of APRIL Mediated Biomarker Responses at the American Society of ...
Monte Rosa Therapeutics Presents Preclinical Data at AHA Scientific Sessions 2025 on the Potential of MRT-8102, a NEK7-directed Molecular Glue Degrader, to Treat Cardiovascular and Cardiometabolic ...
Boost memory, focus & mental clarity with MemoMaster – a clinically inspired brain supplement for sharper thinking, sustained energy & long-term brain health. New York, Nov. 08, 2025 (GLOBE NEWSWIRE) ...
On 30 October 2025, Novo Nordisk announced the submission of an unsolicited proposal to acquire Metsera, Inc. (Metsera) which was declared superior by Metsera’s board of directors.
About China Securities Journal Golden Bull Awards Established by China Securities Journal and approved by national authorities, the Golden Bull Awards are recognized for their rigorous, transparent ...
Smile Spa Camarillo is equipped to provide a full spectrum of services ranging from general, cosmetic, surgical, and emergency dental services. This all-in-one approach reduces the need for external ...
BillionToOne, Inc., a molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all, today announced the closing of its upsized initial public offering ...
Company also expects to publish third quarter 2025 financial results on the same day pre-market ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback